pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2015-25-5-633-637pulmo-632Research ArticleХРОНИКА. ИНФОРМАЦИЯCARRENT EVENTS. INFORMATIONРезолюция Форума экспертов «Российские и международные подходы к вакцинации против пневмококковой инфекции детей и взрослых из групп риска»Resolution of Expert Forum Russian and International Approaches to Vaccination against Pneumococcal Disease in High8Risk Children and AdultsстатьяРедакционнаяArticleEditorial201513012016255633637Copyright © статья Р., 20162016статья Р.article E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/632
.
.
ReferencesЧучалин А.Г., Биличенко Т.Н., Костинов М.П. и др. Вакцинопрофилактика болезней органов дыхания в рамках первичной медикосанитарной помощи населению. Клинические рекомендации. Пульмонология: прил.; 2015; 25 (2).Chuchalin A.G., Bilichenko T.N., Kostinov M.P. et al. Preventive vaccination against respiratory diseases in primary care. Clinical guidelines. Pul'monologiya: pril.; 2015; 25 (2).Министерство здравоохранения Российской Федерации, Союз педиатров России, Национальная ассоциация специалистов по контролю инфекций, связанных с оказанием медицинской помощи (НАСКИ) Вакцинопрофилактика пневмококковой инфекции. Федеральные клинические рекомендации. Москва; 2015.Preventive Vaccination Against Pneumococcal Infection. Federal guidelines of Healthcare Ministry of Russia, The Union of Pediatricians of Russia, National Association of Specialists of Healthcarerelated Infection Control. Moscow; 2015 (in Russian).Use of 13valent pneumococcal conjugate vaccine and 23valent pneumococcal polysaccharide vaccine among adults aged ≥ 65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2014; 63 (37): 822–825.Use of 13valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine among adults aged ≥ 65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2014; 63 (37): 822–825.Use of 13valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2012; 61 (40): 816–819.Use of 13valent pneumococcal conjugate vaccine and 23valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2012; 61 (40): 816–819.Николенко В.В., Фельдблюм И.В., Воробьева Н.Н. и др. Опыт использования иммунохроматографического теста для диагностики пневмококковой пневмонии. Журнал микробиологии, эпидемиологии и иммунобиологии. 2015; 3: 18–24.Nikolenko V.V., Fel'dblyum I.V., Vorob'eva N.N. et al. An experience of diagnosing pneumococcal disease using immunochromatographic test. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2015; 3: 18–24 (in Russian).Методические рекомендации «Иммунизация полисахаридной поливалентной вакциной для профилактики пневмококковой инфекции», утв. Главным государственным санитарным врачом РФ 08.02.08. № 01/816 834.Methodological guidelines 'Immunization with polysac charide polyvalent vaccine for preventing pneumococcal infection'. Approved by Chief Medical Officer of Health of Russian Federation, Feb. 02, 2008, N 01/816834 (in Russian).Bonten M.J., Huijts S.M., Bolkenbaas M. et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N. Engl. J. Med. 2015; 372 (12): 1114–1125.Bonten M.J., Huijts S.M., Bolkenbaas M. et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N. Engl. J. Med. 2015; 372 (12): 1114–1125.Weinberger D.M., Bruhn C.A., Shapiro E.D. Vaccine against pneumococcal pneumonia in adults. N. Engl. J. Med. 2015; 373 (1): 91–93.Weinberger D.M., Bruhn C.A., Shapiro E.D. Vaccine against pneumococcal pneumonia in adults. N. Engl. J. Med. 2015; 373 (1): 91–93.Empfehlung zur Indikationsimpfung gegen Pneumokokken. www.rki.de/EN/Content/Prevention/Vaccination/recomman' dations/34_2014_engl_19215.pdf?_blob=publicationFileEmpfehlung zur Indikationsimpfung gegen Pneumokokken. www.rki.de/EN/Content/Prevention/Vaccination/recomman'dations/34_2014_engl_19215.pdf?_blob=publicationFileCalendrier des vaccinations et recommandations vaccinales 2015. www.sante.gouv.fr/IMG/pdf/Calendrier_vaccinal_2015.pdfCalendrier des vaccinations et recommandations vaccinales 2015. www.sante.gouv.fr/IMG/pdf/Calendrier_vaccinal_2015.pdfGreen Book. Immunisation against infectious disease. Pneumococcal: the green book, chapter 25. www.gov.uk/government/publications/pneumococcal'the'green'book'chapter'25Green Book. Immunisation against infectious disease. Pneumococcal: the green book, chapter 25. www.gov.uk/government/publications/pneumococcal'the'green'book' chapter'25Малахов А.Б., Харит С.М., Крамарь Л.В. и др. Эффективность региональных программ вакцинопрофилактики пневмококковой инфекции в детском возрасте. Здравоохранение. 2014; 1: 113–126.Malakhov A.B., Kharit S.M., Kramar' L.V. et al. Effective ness of regional programmes of preventive vaccination against pneumococcal infection in children. Zdravookhranenie. 2014; 1: 113–126 (in Russian).Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; 1: CD000422.Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. 2013; 1: CD000422.Протокол ведения больных «Хроническая обструктивная болезнь легких» (утв. Минздравсоцразвития России 04.07.05). М., 2005.Chronic obstructive pulmonary disease. A protocol of man agement (approved by Healthcare Ministry of Russia, July 04, 2005). Moscow; 2005 (in Russian).Родионова О.В., Игнатова Г.Л., Блинова Е.В. и др. Опыт применения вакцины Пневмо 23 у пациентов с хронической обструктивной болезнью легких в сочетании с пневмокониозами. Медицина труда и промышленная экология. 2014; 10: 20–24.Rodionova O.V., Ignatova G.L., Blinova E.V. et al. An experience of vaccination with Pneumo23 vaccine in patients with chronic obstructive pulmonary disease and pneumoconiosis. Meditsina truda i promyshlennaya ekologiya. 2014; 10: 20–24 (in Russian).Белевский А.С., Мещерякова Н.Н. Эффективность вакцинации полисахаридной пневмококковой вакциной Пневмо23 пациентов с хронической обструктивной болезнью легких в городских поликлиниках г. Москвы. Практическая пульмонология. 2014; 3: 32–36.Belevskiy A.S., Meshcheryakova N.N. Efficacy of vaccination with polysaccharide pneumococcal vaccine Pneumo23 in patients with chronic obstructive pulmonary disease in Moscow city outpatient clinics. Prakticheskaya pulmonologiya. 2014; 3: 32–36 (in Russian).
The authors declare that there are no conflicts of interest present.